Paul
Analyst
UBS
Equibles does not estimate personal net worth.
About Paul
Paul is recorded as Analyst at UBS. Paul has spoken on 5 earnings calls and 5 other investor events across 10 companies, most recently for Biomarin Pharmaceutical Inc on November 11, 2026. Those appearances were for Biomarin Pharmaceutical Inc (BMRN), Rhythm Pharmaceuticals, Inc. (RYTM), Denali Therapeutics Inc. (DNLI), Korsana Biosciences, Inc. (KRSA), City Therapeutics, Inc. (CTY) and 5 other companies. The companies whose calls Paul spoke on are classified in the Healthcare, Real Estate and Consumer Cyclical sectors.
Paul on recent calls
“Happy to be moderating a chat here with the Baumarin management team. I think Brian, CFO, which I'm sure everybody knows, is going to make some opening remarks, and then I think we're going to use this as an opportunity to spend some time with Greg and talk more about the pipeline that Baumarin's building out.”
“Happy to be here with Hunter Smith, CFO of Rhythm Pharmaceuticals.”
“Happy to be moderating this chat with Joe Lukak, Chief Scientific Officer of Denali Therapeutics.”
“Happy to be here moderating a fireside chat with Jonathan Violin, president and CEO of Corsana Biosciences.”
“Super excited to be moderating this panel with Andy Orth, CEO of City Therapeutics, a next-gen SRNA company that recently went public. Maybe just given you guys are a newly public company, Andy, I'll let you kind of give a little bit of background on the company, your key programs.”
Affiliation history
-
UBS
Analyst
Source not stated
Current
Company network
Apparel Manufacturing · Consumer Cyclical
THE UNITE GROUP PLC
REIT - Diversified · Real Estate
VGP
Real Estate Services · Real Estate
Recent activity
-
-
-
-
-
-
-
-
-
Earnings call
Unite Group 2025 Financial Results Prelims Webcast
THE UNITE GROUP PLC
-
Earnings call
Review of VGP’s financial results over FY 2025
VGP